N.Y. A.G. James Calls for Urgent Action to Protect Children From Harmful Effects of Asthma and Allergy Drug Singulair
February 23, 2024
February 23, 2024
NEW YORK, Feb. 23 (TNSres) -- New York Attorney General Letitia James issued the following news release:
New York Attorney General Letitia James called on the U.S. Food and Drug Administration (FDA) (https://ag.ny.gov/sites/default/files/letters/fda-letter-re-singulair.pdf) to take urgent action to address the potential dangers of the asthma and allergy drug montekulast, known by the brand name Singulair. Singulair has been linked to harmful behavioral and mental health issues among . . .
New York Attorney General Letitia James called on the U.S. Food and Drug Administration (FDA) (https://ag.ny.gov/sites/default/files/letters/fda-letter-re-singulair.pdf) to take urgent action to address the potential dangers of the asthma and allergy drug montekulast, known by the brand name Singulair. Singulair has been linked to harmful behavioral and mental health issues among . . .